Custom Peptides
Cayman Chemical AM694 NpentnoIc ACD metao 10mg
An expected urinary metabolite of AM694, based on the known metabolism of similar compounds; intended for forensic and research applications
Cayman Chemical 16phenoxy ttrnor PROSGla 10mg
16-phenoxy tertanor PGF2α is a metabolically stable analog of PGF2α. It binds to the FP receptor on ovine luteal cells with much greater affinity (440%) than PGF2α.{2058}
Cayman Chemical 5-AEDBhydrochlorIde 10mg
An analytical reference standard categorized as a benzofuran; has been found in samples seized by law enforcement; intended for research and forensic applications
Cayman Chemical SureLIghtAlophycocynInA 10mg
Immunogen Synthetic peptide from the C-terminal region of human nNOS Host Rabbit Cross Reactivity (−) eNOS and iNOS Species Reactivity ( ) Human and rat Applications ICC IHC and WB
Cayman Chemical 4-CABhydrochlorIde 10mg
An analog of PCA; inhibits the reuptake of serotonin (IC50 = 330 nM) and dopamine (IC50 = 2.3 μM)
Cayman Chemical 1 4MethoxyphenylpIperazIn 10mg
A piperazine derivative assumed to have a mixed mechanism of action, with serotonergic and dopamine antagonistic properties in a similar fashion to 3,4-methylenedioxymethamphetamine; intended for research and forensic purposes
Cayman Chemical 6a-ProstaglndIn I1 10mg
6α-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions. 6α-PGI1 promotes cAMP accumulation in human thyroid slices and cells in a concentration dependent manner. However, it is about 10-fold less potent than the β-isomer and 100-fold less potent than PGI2 in eliciting the response.{11172} 6α-PGI1 exhibits an IC50 of 350 ng/ml for inhibition of ADP-induced platelet aggregation, which is nearly 900-fold higher than that observed for PGI2 (0.4 ng/ml).{11183}
Cayman Chemical 2MethoxymethcathInonhydro 10mg
A positional isomer of methedrone, having the methoxy group at the 2 rather than the 4 position; intended for forensic and research applications
Cayman Chemical 3-AcetylmorphIn 10mg
A less active metabolite of heroin with relatively weak affinity for µ-opioid receptors; intended only for forensic and research purposes
Cayman Chemical BromfenacsodIum salt 10mg
A COX-2 inhibitor (IC50 = 6.6 nM); selective over COX-1 (IC50 = 210 nM); inhibits PGE2 production in a rabbit model of LPS-induced eye inflammation; decreases inflammation following cataract removal in dogs (0.9% topically on a tapering schedule for 24 weeks)
Cayman Chemical PerhexIlInmaleate 10mg
A CPT1 and CPT2 inhibitor that inhibits rat heart and liver CPT1 (IC50 = 77 and 148 µM, respectively), and rat heart CPT2 (IC50 = 79 µM); inhibits mTORC1 signaling and induces autophagy in MCF-7 cells at low µM levels
Cayman Chemical ElIptIcInhydrochlorIde 10mg
A DNA-intercalating antitumor agent that forms covalent adducts in DNA after being enzymatically activated with CYP3A4, CYP1A1, or CYP1A2 or by peroxidases in target tissues; inhibits the proliferation of human breast adenocarcinoma, leukemia, neuroblastoma, and glioblastoma cells (IC50s = 0.27-4.7 µM)
Cayman Chemical 2-AmIno-1-phenylbutnhydro 10mg
An amphetamine characterized by having an ethyl group in the alpha position; partially substitutes for D-amphetamine in an animal discrimination analysis
Cayman Chemical BLEBBISTATIN 10MG
A cell-permeable inhibitor of non-muscle myosin II ATPases; inhibits Mg-ATPase activity and in vitro motility of non-muscle myosin IIA and IIB for several species (IC50s = 0.5-5 µM); poorly inhibits smooth muscle myosin (IC50 = 80 µM); (S)-nitro-blebbistatin is a more stable form of (-)-Blebbistatin